A Clinical Trial of Acyclovir for Viral Uveitis

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This project is designed to test the hypothesis that acyclovir is clinically useful for patients with refractory viral uveitis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Xiaomin Zhang
• Treatments: Acyclovir

Criteria

Inclusion Criteria:

• Age between 18 and above.

• Chronic, vision threatening viral uveitis.

• Patients can't tolerate hormone therapy bacause of drug side effects.

• Consent to undergo anterior chamber tap and give aqueous for the study.

• Able to undergo relevant tests.

• Able to come for subsequent follow-up visits.

• Ability to provide informed consent.

Exclusion Criteria:

• Patients who are allergic to ayclovir.

• Immunocompromised patients

• Positive for HIV, Hep B and Hep C

• Not keen on participating in the study

• Patients who are incapable, either by law or mental state, of giving consents in their own right.

• Patients who are either unable or unwilling to keep scheduled appointments and adhere to the other aspects of the protocol.

• Patients who are pregnant or breastfeeding.

• Any other specified reason as determined by the clinical investigator.